These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 8029157

  • 1. [Influence of cuprophane membrane surface dialyzers on beta2-microglobulin serum concentration in patients during hemodialysis].
    Szepietowski T, el-Hayek A.
    Polim Med; 1993; 23(3-4):43-54. PubMed ID: 8029157
    [Abstract] [Full Text] [Related]

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M, Haufe CC, Eismann U, Deppisch RM, Stein G, Wolf G.
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [Abstract] [Full Text] [Related]

  • 3. [What is the reason for the increase in beta-2-microglobulin levels in the blood when using cuprophane dialysis membranes?].
    Sulková S, Lapcík O, Votruba T.
    Cas Lek Cesk; 1989 Apr 21; 128(17):520-3. PubMed ID: 2665936
    [Abstract] [Full Text] [Related]

  • 4. Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane.
    Sethi D, Gower PE.
    Nephrol Dial Transplant; 1988 Apr 21; 3(6):768-72. PubMed ID: 3147418
    [Abstract] [Full Text] [Related]

  • 5. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT, Williams AW, Johnson WJ.
    J Lab Clin Med; 1994 Apr 21; 123(4):495-505. PubMed ID: 8144998
    [Abstract] [Full Text] [Related]

  • 6. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
    Szepietowski T, Krajewska M.
    Polim Med; 1997 Apr 21; 27(1-2):47-59. PubMed ID: 9380601
    [Abstract] [Full Text] [Related]

  • 7. Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility.
    Bommer J, Seelig P, Seelig R, Geerlings W, Bommer G, Ritz E.
    Nephrol Dial Transplant; 1987 Apr 21; 2(1):22-5. PubMed ID: 3110692
    [Abstract] [Full Text] [Related]

  • 8. [Changes in the beta 2-microglobulin level during hemodialysis].
    Nikitinskaia LP, Stetsiuk EA, Iarmolinskiĭ IS, Barinov AV, Kon'kova TA.
    Urol Nefrol (Mosk); 1990 Apr 21; (5):29-31. PubMed ID: 2264202
    [Abstract] [Full Text] [Related]

  • 9. Beta 2-microglobulin kinetics during haemodialysis and haemofiltration.
    Flöge J, Granolleras C, Bingel M, Deschodt G, Branger B, Oules R, Koch KM, Shaldon S.
    Nephrol Dial Transplant; 1987 Apr 21; 1(4):223-8. PubMed ID: 3110678
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D.
    Acta Med Croatica; 2004 Apr 21; 58(1):31-6. PubMed ID: 15125391
    [Abstract] [Full Text] [Related]

  • 11. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
    Petersen J, Moore RM, Kaczmarek RG, Singh B, Yeh I, Hamburger S, Kankam M.
    Am J Kidney Dis; 1991 Feb 21; 17(2):174-8. PubMed ID: 1992659
    [Abstract] [Full Text] [Related]

  • 12. Relationship between serum beta 2-microglobulin, bone histology, and dialysis membranes in uraemic patients.
    Ferreira A, Ureña P, Ang KS, Simon P, Morieux C, Souberbielle JC, de Vernejoul MC, Drüeke TB.
    Nephrol Dial Transplant; 1995 Feb 21; 10(9):1701-7. PubMed ID: 8559492
    [Abstract] [Full Text] [Related]

  • 13. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA, Woffindin C, Cox PJ, Goldfinch M, Roberts SJ.
    Clin Nephrol; 1997 Oct 21; 48(4):253-9. PubMed ID: 9352161
    [Abstract] [Full Text] [Related]

  • 14. Serum beta 2 microglobulin and extracellular fluid volume during haemodialysis.
    Chanard J, Toupance O, Lavaud S, Jaisser F, Gillery P.
    Nephrol Dial Transplant; 1989 Oct 21; 4(6):549-54. PubMed ID: 2507977
    [Abstract] [Full Text] [Related]

  • 15. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis.
    Vanholder RC, Ringoir SM.
    Blood Purif; 1990 Oct 21; 8(1):32-44. PubMed ID: 2198890
    [Abstract] [Full Text] [Related]

  • 16. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A, Szepietowski T.
    Polim Med; 1992 Oct 21; 22(1-2):59-72. PubMed ID: 1461837
    [Abstract] [Full Text] [Related]

  • 17. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
    Mayer G, Thum J, Woloszczuk W, Graf H.
    Am J Nephrol; 1988 Oct 21; 8(4):280-4. PubMed ID: 3055992
    [Abstract] [Full Text] [Related]

  • 18. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
    Starzyk J, Kowalski D.
    Wiad Lek; 1993 Apr 21; 46(7-8):283-5. PubMed ID: 8249416
    [Abstract] [Full Text] [Related]

  • 19. [Dialysis amyloidosis and beta-2-microglobulin].
    Sulková S, Votruba T.
    Cas Lek Cesk; 1989 Jan 13; 128(3):68-73. PubMed ID: 2655913
    [Abstract] [Full Text] [Related]

  • 20. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
    Okuno S, Ishimura E, Kohno K, Fujino-Katoh Y, Maeno Y, Yamakawa T, Inaba M, Nishizawa Y.
    Nephrol Dial Transplant; 2009 Feb 13; 24(2):571-7. PubMed ID: 18799606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.